[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Pain Management Devices Market By Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices) By Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications) By Region, Industry Analysis and Forecast, 2020 - 2026

May 2020 | 181 pages | ID: G49342494A02EN
KBV Research

US$ 3,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Pain Management Devices Market size is expected to reach $6.3 billion by 2026, rising at a market growth of 8.5% CAGR during the forecast period. Pain management is a branch of medical science that relieves patients with chronic pain from their suffering. Acute pain has a sudden onset of action, while chronic pain persists for a longer period of time, which leads to the need for its control. Pain management devices are medical devices used to relieve different forms of pressure such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain among others. Stimulators for the spinal cord, transcutaneous electrical nerve stimulators, analgesic infusion pumps, and ablation devices are different types of pain management devices available on the market.

With Covid-19 infections rising globally, there is also deepening apprehension about a shortage of essential life-saving devices and other essential medical supplies to prevent the spread of this pandemic and provide optimum care to those infected. Additionally, for COVID-19 patients, who may require critical care, ventilators act as a vital treatment preference until a pharmacological treatment is developed. In addition, a wide range of test-kits (antibody tests, self-administered, and others) involves a fast acceleration in the manufacturing phase.

Growth in the global market for pain management devices is driven by the increase in geriatric population, a rise in chronic pain pervasiveness, growing awareness of people's awareness of pain management devices, improved investment in R&D to develop innovative products and the launch of new products. Additionally, growing demand for pain management devices in emerging countries and increasing the use of pain management devices for chronic pain management are other factors contributing to market growth. In addition, the untapped potential offered by developing economies is presenting lucrative market expansion opportunities over the forecast period. Nevertheless, reactions to hypersensitivity and postoperative infections caused by the use of these devices restrict their adoption, which hampers the market growth.

Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are Partnerships and Acquisition. Based on the Analysis presented in the Cardinal matrix, Johnson and Johnson and Pfizer, Inc. are the forerunners in the Pain Management Devices Market. Companies such as Boston Scientific Corporation, Medtronic PLC, Colfax Corporation, Stryker Corporation, Kimberly-Clark Corporation, and Abbott Laboratories, Baxter International, Inc., and B. Braun Melsungen AG are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)

Recent strategies deployed in Pain Management Devices Market

Partnerships, Collaborations, and Agreements:

May-2020: Medtronic collaborated with UW following which the company has accelerated research into deep brain stimulation treatment for essential tremor, Parkinson’s disease, and other neurological disorders.

May-2019: Abbott came into partnership with the US National Institutes of Health (NIH). The partnership was aimed at developing unique insights and driving the application of neurostimulation therapies. The partnership would provide the latter company's neuroscience research initiative BRAIN access to Abbott’s neuromodulation technologies.

Approvals:
Jan-2020: Abbott Laboratories got approval from the US Food and Drug Administration (FDA) for its Infinity Deep Brain Stimulation (DBS) system. This system would be used in the treatment of Parkinson’s disease. The system would enable targeting a specific area of the brain known as the internal globus pallidus (GPi) for improving the symptoms of Parkinson’s disease not controlled by medication.
Jan-2020: Medtronic secured a CE Mark for its Percept PC neurostimulator. It is the only deep brain stimulation (DBS) system launched in the EU with BrainSense technology, which senses and records brain signals while delivering DBS therapy to people with neurological disorders such as Parkinson’s disease.
Sep-2019: Abbott announced that the U.S. Food and Drug Administration (FDA) approved its Proclaim XR recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platform provides a low dose of Abbott's proprietary BurstDR stimulation waveform, which was created based on scientific insights from doctors and researchers to mimic natural patterns found in the brain. It works by using low doses of mild electrical pulses to change pain signals as they travel from the spinal cord to the brain.
Acquisition and Mergers:
Jan-2020: Medtronic took over Stimgenics, a startup company that has developed a novel spinal cord stimulation waveform. This acquisition enabled the company to expand its business in the SCS Market.
Jun-2019: Boston Scientific acquired Vertiflex, a healthcare company. Through this acquisition, Vertiflex's spinal cord stimulation and radiofrequency ablation have been added to Boston Scientific's product portfolio.
Oct-2017: Stryker Corporation took over VEXIM, a medical device company specializing in the minimally invasive treatment of vertebral fractures. Through this acquisition, Stryker enabled the latter company to become a global leader in trauma and expanded its geographical foothold.
Jun-2017: DePuy Synthes Products, Inc., part of the Johnson & Johnson Medical Devices Companies acquired Innovative Surgical Solutions, LLC, doing business as Sentio, LLC, a company that markets innovative nerve localization technology for spine surgery. The acquisition strengthened its spine portfolio in decompression procedures as well as lateral surgery and developed a platform for future innovation in minimally invasive surgery.
Jul-2016: Boston took over Cosman Medical following which Cosman operates under the Boston Scientific Neuromodulation business. Following the acquisition, the company aimed to offer a wide range of spinal cord stimulator (SCS) systems to the patients suffering from chronic pain.
Product Launches and Product Expansions:
Jan-2019: Boston Scientific introduced the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems. The systems feature the Vercise Cartesia Directional Lead. The systems have the technology that enables the physicians in controlling the range, shape, position, and direction of electrical stimulation to treat the symptoms of Parkinson's disease (PD) through highly-personalized therapy.
Jan-2019: Boston launched WaveWriter Spinal Cord Stimulator (SCS) System in Europe for providing the treatment of chronic pain to people in Europe.

Scope of the Study

Market Segmentation:

By Product
  • Neuromodulation & Neurostimulation Devices
  • Analgesic Infusion Pumps and
  • Ablation Devices
By Application
  • Neuropathic Pain
  • Musculoskeletal Pain
  • Cancer Pain
  • Facial & Migraine Pain and
  • Other Applications
By Geography
  • North America
    • US
    • Canada
        • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Companies Profiled
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Boston Scientific Corporation
  • Johnson and Johnson
  • Medtronic PLC
  • Kimberly-Clark Corporation
  • Stryker Corporation
  • Colfax Corporation (DJO Global, Inc.)
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Global Pain Management Devices Market, by Product
  1.4.2 Global Pain Management Devices Market, by Application
  1.4.3 Global Pain Management Devices Market, by Geography
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. COMPETITION ANALYSIS - GLOBAL

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
  3.2.1 Partnerships, Collaborations and Agreements
  3.2.2 Product Launches and Product Expansions
  3.2.3 Mergers & Acquisitions
  3.2.4 Approvals
3.3 Top Winning Strategies
  3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
  3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players

CHAPTER 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT

4.1 Global Neuromodulation & Neurostimulation Devices Market by Region
4.2 Global Analgesic Infusion Pumps Market by Region
4.3 Global Ablation Devices Market by Region

CHAPTER 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET BY APPLICATION

5.1 Global Neuropathic Pain Market by Region
5.2 Global Musculoskeletal Pain Market by Region
5.3 Global Cancer Pain Market by Region
5.4 Global Facial & Migraine Pain Market by Region
5.5 Global Other Applications Market by Region

CHAPTER 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET BY REGION

6.1 North America Pain Management Devices Market
  6.1.1 North America Pain Management Devices Market by Product
    6.1.1.1 North America Neuromodulation & Neurostimulation Devices Market by Country
    6.1.1.2 North America Analgesic Infusion Pumps Market by Country
    6.1.1.3 North America Ablation Devices Market by Country
  6.1.2 North America Pain Management Devices Market by Application
    6.1.2.1 North America Neuropathic Pain Market by Country
    6.1.2.2 North America Musculoskeletal Pain Market by Country
    6.1.2.3 North America Cancer Pain Market by Country
    6.1.2.4 North America Facial & Migraine Pain Market by Country
    6.1.2.5 North America Other Applications Market by Country
  6.1.3 North America Pain Management Devices Market by Country
    6.1.3.1 US Pain Management Devices Market
      6.1.3.1.1 US Pain Management Devices Market by Product
      6.1.3.1.2 US Pain Management Devices Market by Application
    6.1.3.2 Canada Pain Management Devices Market
      6.1.3.2.1 Canada Pain Management Devices Market by Product
      6.1.3.2.2 Canada Pain Management Devices Market by Application
    6.1.3.3 Mexico Pain Management Devices Market
      6.1.3.3.1 Mexico Pain Management Devices Market by Product
      6.1.3.3.2 Mexico Pain Management Devices Market by Application
    6.1.3.4 Rest of North America Pain Management Devices Market
      6.1.3.4.1 Rest of North America Pain Management Devices Market by Product
      6.1.3.4.2 Rest of North America Pain Management Devices Market by Application
6.2 Europe Pain Management Devices Market
  6.2.1 Europe Pain Management Devices Market by Product
    6.2.1.1 Europe Neuromodulation & Neurostimulation Devices Market by Country
    6.2.1.2 Europe Analgesic Infusion Pumps Market by Country
    6.2.1.3 Europe Ablation Devices Market by Country
  6.2.2 Europe Pain Management Devices Market by Application
    6.2.2.1 Europe Neuropathic Pain Market by Country
    6.2.2.2 Europe Musculoskeletal Pain Market by Country
    6.2.2.3 Europe Cancer Pain Market by Country
    6.2.2.4 Europe Facial & Migraine Pain Market by Country
    6.2.2.5 Europe Other Applications Market by Country
  6.2.3 Europe Pain Management Devices Market by Country
    6.2.3.1 Germany Pain Management Devices Market
      6.2.3.1.1 Germany Pain Management Devices Market by Product
      6.2.3.1.2 Germany Pain Management Devices Market by Application
    6.2.3.2 UK Pain Management Devices Market
      6.2.3.2.1 UK Pain Management Devices Market by Product
      6.2.3.2.2 UK Pain Management Devices Market by Application
    6.2.3.3 France Pain Management Devices Market
      6.2.3.3.1 France Pain Management Devices Market by Product
      6.2.3.3.2 France Pain Management Devices Market by Application
    6.2.3.4 Russia Pain Management Devices Market
      6.2.3.4.1 Russia Pain Management Devices Market by Product
      6.2.3.4.2 Russia Pain Management Devices Market by Application
    6.2.3.5 Spain Pain Management Devices Market
      6.2.3.5.1 Spain Pain Management Devices Market by Product
      6.2.3.5.2 Spain Pain Management Devices Market by Application
    6.2.3.6 Italy Pain Management Devices Market
      6.2.3.6.1 Italy Pain Management Devices Market by Product
      6.2.3.6.2 Italy Pain Management Devices Market by Application
    6.2.3.7 Rest of Europe Pain Management Devices Market
      6.2.3.7.1 Rest of Europe Pain Management Devices Market by Product
      6.2.3.7.2 Rest of Europe Pain Management Devices Market by Application
6.3 Asia Pacific Pain Management Devices Market
  6.3.1 Asia Pacific Pain Management Devices Market by Product
    6.3.1.1 Asia Pacific Neuromodulation & Neurostimulation Devices Market by Country
    6.3.1.2 Asia Pacific Analgesic Infusion Pumps Market by Country
    6.3.1.3 Asia Pacific Ablation Devices Market by Country
  6.3.2 Asia Pacific Pain Management Devices Market by Application
    6.3.2.1 Asia Pacific Neuropathic Pain Market by Country
    6.3.2.2 Asia Pacific Musculoskeletal Pain Market by Country
    6.3.2.3 Asia Pacific Cancer Pain Market by Country
    6.3.2.4 Asia Pacific Facial & Migraine Pain Market by Country
    6.3.2.5 Asia Pacific Other Applications Market by Country
  6.3.3 Asia Pacific Pain Management Devices Market by Country
    6.3.3.1 China Pain Management Devices Market
      6.3.3.1.1 China Pain Management Devices Market by Product
      6.3.3.1.2 China Pain Management Devices Market by Application
    6.3.3.2 Japan Pain Management Devices Market
      6.3.3.2.1 Japan Pain Management Devices Market by Product
      6.3.3.2.2 Japan Pain Management Devices Market by Application
    6.3.3.3 India Pain Management Devices Market
      6.3.3.3.1 India Pain Management Devices Market by Product
      6.3.3.3.2 India Pain Management Devices Market by Application
    6.3.3.4 South Korea Pain Management Devices Market
      6.3.3.4.1 South Korea Pain Management Devices Market by Product
      6.3.3.4.2 South Korea Pain Management Devices Market by Application
    6.3.3.5 Singapore Pain Management Devices Market
      6.3.3.5.1 Singapore Pain Management Devices Market by Product
      6.3.3.5.2 Singapore Pain Management Devices Market by Application
    6.3.3.6 Malaysia Pain Management Devices Market
      6.3.3.6.1 Malaysia Pain Management Devices Market by Product
      6.3.3.6.2 Malaysia Pain Management Devices Market by Application
    6.3.3.7 Rest of Asia Pacific Pain Management Devices Market
      6.3.3.7.1 Rest of Asia Pacific Pain Management Devices Market by Product
      6.3.3.7.2 Rest of Asia Pacific Pain Management Devices Market by Application
6.4 LAMEA Pain Management Devices Market
  6.4.1 LAMEA Pain Management Devices Market by Product
    6.4.1.1 LAMEA Neuromodulation & Neurostimulation Devices Market by Country
    6.4.1.2 LAMEA Analgesic Infusion Pumps Market by Country
    6.4.1.3 LAMEA Ablation Devices Market by Country
  6.4.2 LAMEA Pain Management Devices Market by Application
    6.4.2.1 LAMEA Neuropathic Pain Market by Country
    6.4.2.2 LAMEA Musculoskeletal Pain Market by Country
    6.4.2.3 LAMEA Cancer Pain Market by Country
    6.4.2.4 LAMEA Facial & Migraine Pain Market by Country
    6.4.2.5 LAMEA Other Applications Market by Country
  6.4.3 LAMEA Pain Management Devices Market by Country
    6.4.3.1 Brazil Pain Management Devices Market
      6.4.3.1.1 Brazil Pain Management Devices Market by Product
      6.4.3.1.2 Brazil Pain Management Devices Market by Application
    6.4.3.2 Argentina Pain Management Devices Market
      6.4.3.2.1 Argentina Pain Management Devices Market by Product
      6.4.3.2.2 Argentina Pain Management Devices Market by Application
    6.4.3.3 UAE Pain Management Devices Market
      6.4.3.3.1 UAE Pain Management Devices Market by Product
      6.4.3.3.2 UAE Pain Management Devices Market by Application
    6.4.3.4 Saudi Arabia Pain Management Devices Market
      6.4.3.4.1 Saudi Arabia Pain Management Devices Market by Product
      6.4.3.4.2 Saudi Arabia Pain Management Devices Market by Application
    6.4.3.5 South Africa Pain Management Devices Market
      6.4.3.5.1 South Africa Pain Management Devices Market by Product
      6.4.3.5.2 South Africa Pain Management Devices Market by Application
    6.4.3.6 Nigeria Pain Management Devices Market
      6.4.3.6.1 Nigeria Pain Management Devices Market by Product
      6.4.3.6.2 Nigeria Pain Management Devices Market by Application
    6.4.3.7 Rest of LAMEA Pain Management Devices Market
      6.4.3.7.1 Rest of LAMEA Pain Management Devices Market by Product
      6.4.3.7.2 Rest of LAMEA Pain Management Devices Market by Application

CHAPTER 7. COMPANY PROFILES

7.1 Abbott Laboratories
  7.1.1 Company Overview
  7.1.2 Financial Analysis
  7.1.3 Segmental and Regional Analysis
  7.1.4 Research & Development Expense
  7.1.5 Recent strategies and developments:
    7.1.5.1 Partnerships, Collaborations, and Agreements:
    7.1.5.2 Approvals:
7.2 B. Braun Melsungen AG
  7.2.1 Company Overview
  7.2.2 Financial Analysis
  7.2.3 Segmental Analysis
  7.2.4 Research & Development Expense
7.3 Baxter International, Inc.
  7.3.1 Company Overview
  7.3.2 Financial Analysis
  7.3.3 Regional Analysis
  7.3.4 Research & Development Expense
  7.3.5 Recent strategies and developments:
    7.3.5.1 Approvals:
7.4 Pfizer, Inc.
  7.4.1 Company Overview
  7.4.2 Financial Analysis
  7.4.3 Segmental and Regional Analysis
  7.4.4 Research & Development Expense
7.5 Boston Scientific Corporation
  7.5.1 Company Overview
  7.5.2 Financial Analysis
  7.5.3 Segmental and Regional Analysis
  7.5.4 Research & Development Expense
  7.5.5 Recent strategies and developments:
    7.5.5.1 Acquisition and Mergers:
    7.5.5.2 Product Launches and Product Expansions:
7.6 Johnson and Johnson
  7.6.1 Company Overview
  7.6.2 Financial Analysis
  7.6.3 Segmental &Regional Analysis
  7.6.4 Research & Development Expenses
  7.6.5 Recent strategies and developments:
    7.6.5.1 Acquisition and Mergers:
7.7 Medtronic PLC
  7.7.1 Company overview
  7.7.2 Financial Analysis
  7.7.3 Segmental and Regional Analysis
  7.7.4 Research & Development Expenses
  7.7.5 Recent strategies and developments:
    7.7.5.1 Partnerships, Collaborations, and Agreements:
    7.7.5.2 Approvals:
    7.7.5.3 Acquisition and Mergers:
    7.7.5.4 Product Launches and Product Expansions:
7.8 Kimberly-Clark Corporation
  7.8.1 Company Overview
  7.8.2 Financial Analysis
  7.8.3 Segmental and Regional Analysis
  7.8.4 Research & Development Expense
7.9 Stryker Corporation
  7.9.1 Company Overview
  7.9.2 Financial Analysis
  7.9.3 Segmental and Regional Analysis
  7.9.4 Research & Development Expense
  7.9.5 Recent strategies and developments:
    7.9.5.1 Acquisition and Mergers:
7.1 Colfax Corporation (DJO Global, Inc.)
  7.10.1 Company Overview
  7.10.2 Financial Analysis
  7.10.3 Segmental and Regional Analysis
  7.10.4 Research & Development Expense
  7.10.5 Recent strategies and developments:
    7.10.5.1 Product Launches and Product Expansions:

LIST OF TABLES

TABLE 1 GLOBAL PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 GLOBAL PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– PAIN MANAGEMENT DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– PAIN MANAGEMENT DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – PAIN MANAGEMENT DEVICES MARKET
TABLE 6 APPROVALS – PAIN MANAGEMENT DEVICES MARKET
TABLE 7 GLOBAL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 8 GLOBAL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 9 GLOBAL NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 10 GLOBAL NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 11 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 12 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 13 GLOBAL ABLATION DEVICES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 14 GLOBAL ABLATION DEVICES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 15 GLOBAL PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 GLOBAL PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 GLOBAL NEUROPATHIC PAIN MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 18 GLOBAL NEUROPATHIC PAIN MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 19 GLOBAL MUSCULOSKELETAL PAIN MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 20 GLOBAL MUSCULOSKELETAL PAIN MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 21 GLOBAL CANCER PAIN MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 22 GLOBAL CANCER PAIN MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 23 GLOBAL FACIAL & MIGRAINE PAIN MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 24 GLOBAL FACIAL & MIGRAINE PAIN MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 25 GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 26 GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 27 GLOBAL PAIN MANAGEMENT DEVICES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 28 GLOBAL PAIN MANAGEMENT DEVICES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 29 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 30 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 31 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 32 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 33 NORTH AMERICA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 NORTH AMERICA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 NORTH AMERICA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 NORTH AMERICA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 NORTH AMERICA ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 38 NORTH AMERICA ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 39 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 40 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 41 NORTH AMERICA NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 42 NORTH AMERICA NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 43 NORTH AMERICA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 44 NORTH AMERICA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 45 NORTH AMERICA CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 46 NORTH AMERICA CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 47 NORTH AMERICA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 48 NORTH AMERICA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 49 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 50 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 51 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 52 NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 53 US PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 US PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 US PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 56 US PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 57 US PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 58 US PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 59 MEXICO PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 MEXICO PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 MEXICO PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 62 MEXICO PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 63 MEXICO PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 64 MEXICO PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 65 MEXICO PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 MEXICO PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 MEXICO PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 68 MEXICO PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 69 MEXICO PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 70 MEXICO PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 71 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 72 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 73 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 74 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 75 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 76 REST OF NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 77 EUROPE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 78 EUROPE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 79 EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 80 EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 81 EUROPE NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 82 EUROPE NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 83 EUROPE ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 84 EUROPE ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 85 EUROPE ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 86 EUROPE ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 87 EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 88 EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 89 EUROPE NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 90 EUROPE NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 91 EUROPE MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 92 EUROPE MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 93 EUROPE CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 94 EUROPE CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 95 EUROPE FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 96 EUROPE FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 97 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 98 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 99 EUROPE PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 100 EUROPE PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 101 GERMANY PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 102 GERMANY PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 103 GERMANY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 104 GERMANY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 105 GERMANY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 106 GERMANY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 107 UK PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 108 UK PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 109 UK PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 110 UK PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 111 UK PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 112 UK PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 113 FRANCE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 114 FRANCE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 115 FRANCE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 116 FRANCE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 117 FRANCE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 118 FRANCE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 119 RUSSIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 120 RUSSIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 121 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 122 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 123 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 124 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 125 SPAIN PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 126 SPAIN PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 127 SPAIN PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 128 SPAIN PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 129 SPAIN PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 130 SPAIN PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 131 ITALY PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 132 ITALY PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 133 ITALY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 134 ITALY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 135 ITALY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 136 ITALY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 137 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 138 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 139 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 140 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 141 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 142 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 143 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 144 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 145 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 146 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 147 ASIA PACIFIC NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 148 ASIA PACIFIC NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 149 ASIA PACIFIC ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 150 ASIA PACIFIC ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 151 ASIA PACIFIC ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 152 ASIA PACIFIC ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 153 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 154 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 155 ASIA PACIFIC NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 156 ASIA PACIFIC NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 157 ASIA PACIFIC MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 158 ASIA PACIFIC MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 159 ASIA PACIFIC CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 160 ASIA PACIFIC CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 161 ASIA PACIFIC FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 162 ASIA PACIFIC FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 163 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 164 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 165 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 166 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 167 CHINA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 168 CHINA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 169 CHINA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 170 CHINA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 171 CHINA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 172 CHINA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 173 JAPAN PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 174 JAPAN PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 175 JAPAN PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 176 JAPAN PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 177 JAPAN PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 178 JAPAN PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 179 INDIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 180 INDIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 181 INDIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 182 INDIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 183 INDIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 184 INDIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 185 SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 186 SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 187 SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 188 SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 189 SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 190 SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 191 SINGAPORE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 192 SINGAPORE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 193 SINGAPORE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 194 SINGAPORE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 195 SINGAPORE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 196 SINGAPORE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 197 MALAYSIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 198 MALAYSIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 199 MALAYSIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 200 MALAYSIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 201 MALAYSIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 202 MALAYSIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 203 REST OF ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 204 REST OF ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 205 REST OF ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 206 REST OF ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 207 REST OF ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 208 REST OF ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 209 LAMEA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 210 LAMEA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 211 LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 212 LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 213 LAMEA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 214 LAMEA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 215 LAMEA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 216 LAMEA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 217 LAMEA ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 218 LAMEA ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 219 LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 220 LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 221 LAMEA NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 222 LAMEA NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 223 LAMEA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 224 LAMEA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 225 LAMEA CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 226 LAMEA CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 227 LAMEA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 228 LAMEA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 229 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 230 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 231 LAMEA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 232 LAMEA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 233 BRAZIL PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 234 BRAZIL PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 235 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 236 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 237 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 238 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 239 ARGENTINA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 240 ARGENTINA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 241 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 242 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 243 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 244 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 245 UAE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 246 UAE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 247 UAE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 248 UAE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 249 UAE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 250 UAE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 251 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 252 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 253 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 254 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 255 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 256 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 257 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 258 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 259 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 260 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 261 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 262 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 263 NIGERIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 264 NIGERIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 265 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 266 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 267 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 268 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 269 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 270 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 271 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 272 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 273 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 274 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 275 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 276 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 277 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 278 KEY INFORMATION – PFIZER, INC.
TABLE 279 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 280 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 281 KEY INFORMATION – MEDTRONIC PLC
TABLE 282 KEY INFORMATION – KIMBERLY-CLARK CORPORATION
TABLE 283 KEY INFORMATION – STRYKER CORPORATION
TABLE 284 KEY INFORMATION – COLFAX CORPORATION

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENT: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC

More Publications

Need Help?

Ask a Question

Market Reports

All Categories